COPPI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.888
AS - Asia 1.860
NA - Nord America 1.819
SA - Sud America 306
AF - Africa 74
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.973
Nazione #
US - Stati Uniti d'America 1.786
RU - Federazione Russa 795
SG - Singapore 530
CN - Cina 529
IT - Italia 381
HK - Hong Kong 254
BR - Brasile 242
PL - Polonia 229
KR - Corea 191
VN - Vietnam 122
IE - Irlanda 104
SE - Svezia 81
DE - Germania 72
IN - India 65
FI - Finlandia 55
GB - Regno Unito 39
NL - Olanda 38
ID - Indonesia 37
FR - Francia 36
AU - Australia 25
PK - Pakistan 22
BD - Bangladesh 21
AR - Argentina 20
ES - Italia 19
JO - Giordania 19
EG - Egitto 16
CA - Canada 15
IQ - Iraq 13
JP - Giappone 13
MX - Messico 13
TR - Turchia 13
EC - Ecuador 11
KE - Kenya 10
MA - Marocco 10
CO - Colombia 9
CZ - Repubblica Ceca 9
BJ - Benin 8
GH - Ghana 8
CH - Svizzera 7
UA - Ucraina 7
VE - Venezuela 6
PE - Perù 5
PY - Paraguay 5
ZA - Sudafrica 5
CI - Costa d'Avorio 4
IR - Iran 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
SN - Senegal 3
BE - Belgio 2
BH - Bahrain 2
GR - Grecia 2
LT - Lituania 2
NG - Nigeria 2
SA - Arabia Saudita 2
TH - Thailandia 2
AM - Armenia 1
BN - Brunei Darussalam 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
YT - Mayotte 1
Totale 5.973
Città #
Santa Clara 605
Singapore 407
Ashburn 265
Hong Kong 229
Warsaw 227
Hefei 217
Seoul 187
Dublin 104
Florence 92
Fairfield 74
Beijing 70
Chandler 61
Moscow 50
Ho Chi Minh City 48
Los Angeles 47
Munich 44
Lawrence 32
Altamura 30
Jakarta 29
Buffalo 28
Wilmington 27
Kent 26
Woodbridge 25
Houston 24
New York 23
Seattle 23
Lappeenranta 22
Melbourne 22
São Paulo 21
Turku 19
Boston 18
Milan 18
Princeton 18
Rome 18
Cambridge 17
Hanoi 16
The Dalles 16
Dallas 14
Helsinki 14
Mumbai 14
San Diego 14
West Jordan 12
Bengaluru 11
Frankfurt am Main 11
Tokyo 11
Medford 10
London 9
Paris 9
Shanghai 9
Ann Arbor 8
Cotonou 8
Delhi 8
Haiphong 8
Nairobi 8
Accra 7
Amsterdam 7
Casablanca 7
Chicago 7
Lahore 7
Madrid 7
Pune 7
Cairo 6
Chennai 6
Dong Ket 6
Düsseldorf 6
Hillsboro 6
Kırıkkale 6
Montreal 6
Quito 6
Redwood City 6
Bern 5
Curitiba 5
Denver 5
Guangzhou 5
New Delhi 5
Pardubice 5
Porto Alegre 5
Saidu Sharif 5
Trieste 5
Abidjan 4
Asunción 4
Biên Hòa 4
Boardman 4
Bologna 4
Cagliari 4
Can Tho 4
Canoas 4
Council Bluffs 4
Da Nang 4
Karbala 4
Lauterbourg 4
Mexico City 4
Multan 4
Naples 4
Phoenix 4
Portsmouth 4
Ribeirão Preto 4
San Francisco 4
Tashkent 4
Andover 3
Totale 3.608
Nome #
Novel phenotypic and molecular approaches for tackling the problem of microbial drug resistance 325
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 278
Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids 175
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens 175
Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022 160
Reply: COVID-19: Semen impairment may not be related to the virus 160
Novel resistance ICEs carrying the blaFIM-1 metallo-β-lactamase gene from an ST235 Pseudomonas aeruginosa sublineage 158
A urokinase-associated outbreak of Ralstonia mannitolilytica bloodstream infections in haemodialysis patients in north-eastern Italy, January to April 2023 158
Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods 156
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 151
Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa 151
Male reproductive system inflammation after healing from coronavirus disease 2019 151
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 148
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron 147
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli 144
Population structure of kpc carbapenemase-producing klebsiella pneumoniae in a long-term acute-care rehabilitation facility: Identification of a new lineage of clonal group 101, associated with local hyperendemicity 143
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 140
Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay 140
Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA 139
Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems 137
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 135
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 132
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens 127
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening 126
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 124
Pseudomonas aeruginosa producing FIM-1-metallo-β-lactamase: emergence and cross-transmission in a long-term acute care rehabilitation hospital 121
Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant enterococcus gallinarum isolate 121
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 120
Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system 119
Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples 119
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates 117
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study 115
Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature 114
In vivo evolution to high-level cefiderocol resistance of NDM-1-producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission 113
Resistance and virulence features of hypermucoviscous Klebsiella pneumoniae from bloodstream infections: Results of a nationwide Italian surveillance study 110
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 100
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 100
Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae 99
Chloramphenicol activity against carbapenemase producing Enterobacterales 98
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam 95
Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae 88
Dealing with Challenges Posed by Antimicrobial Resistance in Long-Term Acute-Care Rehabilitation Facilities 84
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses 84
Amelioration of Serum Aβ Levels and Cognitive Impairment in APPPS1 Transgenic Mice Following Symbiotic Administration 81
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 70
Totale 6.048
Categoria #
all - tutte 18.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 25 6 11 15 22 6 15
2021/2022142 5 3 11 6 2 10 16 23 4 9 13 40
2022/2023427 32 104 29 24 10 67 73 10 47 7 11 13
2023/2024424 7 38 43 15 25 54 20 78 17 66 30 31
2024/20252.490 98 219 141 394 529 277 101 175 130 91 146 189
2025/20262.118 388 527 417 355 346 85 0 0 0 0 0 0
Totale 6.048